| abstract |
An object of the present invention is to provide an HIV replication inhibitor that can be a useful research tool for studying the mechanism of HIV replication and the function of LSD1. The following general formula (1) (wherein R 1 represents hydrogen or a phenylamide group, R 2 represents an alkylene group which may have a branch, and the cyclopropylamine substituent is in the meta position or Or a pharmaceutically acceptable salt, hydrate, solvate or prodrug thereof. [Selection] Figure 4 |